This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On June 13, 2019, the new CTS Laboratory Information System was successfully implemented in Cha...
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...